Benzothiazole, 2,7-Dichloro-

In the continuous production of bis(benzothiazolyl)ethylene optical brighteners—specifically those classified under Colour Index Generic Name Fluorescent Brightener 351 (FB 351) and its homologues—2,7-dichlorobenzothiazole undergoes a Knoevenagel-type condensation with terephthalaldehyde at a mole ratio of 2.0 to 2.05 per mole of dialdehyde. The synthesis is executed in a high-boiling aromatic solvent mixture consisting of xylene and a minor fraction of dimethylacetamide, with triethyl phosphite serving as the catalyst at a charge level of 3.5–5.0 mol% relative to the aldehyde. The reaction mass is heated under a nitrogen blanket to 138–145 °C and held for 6–8 hours while water generated by the condensation is azeotropically removed through a Dean-Stark trap. Any residual moisture exceeding 50 ppm in the solvent system has been observed to promote partial hydrolysis of the chlorinated thiazole ring, producing mono-condensed benzaldehyde intermediates that ultimately reduce the brightener’s extinction coefficient by as much as 25%. After completion, the slurry is cooled to 5 °C, the crude product isolated on a nutsche pressure filter under inert gas, reslurried in methanol, and vacuum-dried at 80 °C and 25 mbar until loss on drying is below 0.2%. The final brightener is incorporated into polyester chip via masterbatch extrusion at a let-down ratio yielding 150–250 ppm active brightener in the finished fiber or 80–120 ppm in PET bottle-grade resin, consistent with standard injection-stretch-blow molding temperature profiles. From a regulatory standpoint, the intermediate 2,7-dichlorobenzothiazole must be manufactured under a quality management system audited to ISO 9001:2015, and the downstream optical brightener must satisfy migration limits defined in EU Regulation 10/2011 (specific migration limit for benzothiazole derivatives typically ≤0.05 mg/kg food simulant) and China GB 9685-2016 positive list entries for food-contact materials. Additionally, textile-grade brightener formulations are subject to OEKO-TEX Standard 100 Annex 4 restrictions on fluorescent whitening agents, requiring extraction tests according to DIN 54278-2. The compound’s supply chain for this application demands a purity profile with total organic chlorine content verified by combustion-ion chromatography per ASTM D7359-14a and individual related substances limited to ≤0.15% by HPLC with UV detection at 254 nm. Published data for the influence of agitation type on crystal habit in this specific condensation remain limited, but production batches on 5,000 L glass-lined reactors with retreat-curve impellers routinely achieve yields in excess of 91% of theory when the residual aldehyde content is held below 0.3%.

Why Does Coupling Component Purity Determine Exhaustion Rates in Disperse Dye Synthesis?

When 2,7-dichlorobenzothiazole is employed as a diazo component in heterocyclic disperse dye manufacture, the intermediate is first pulverized and wetted with a dispersing agent before being added to a pre-chilled 30–35% sulfuric acid solution at 0–3 °C inside a glass-lined, jacket-cooled diazotization vessel equipped with anchor agitation. Sodium nitrite, dosed as a 40% aqueous solution, is fed at a rate that maintains a stoichiometric excess of 1.03–1.08 equivalents relative to the amine, monitored by periodic starch–iodide spot tests on potassium iodide turnings; the reaction is held for 2 hours at ≤2 °C to ensure complete conversion, after which residual nitrous acid is destroyed with sulfamic acid. The resulting diazonium salt solution is clarified through a plate filter coated with diatomaceous earth and then transferred to a coupling reactor containing the coupling component—typically a substituted N-ethylaniline or m-toluidine derivative—dissolved in dilute hydrochloric acid at pH 2.5–3.0. Coupling is conducted at a jacket temperature of 8–14 °C under continuous pH monitoring; deviation beyond pH 3.5 during the initial coupling phase increases the rate of diazo-decomposition by more than 40% and generates non-coloring breakdown products that adulterate the final dye’s wash fastness. Production-scale trials on a 2,500 L coupling vessel fitted with a half-coil jacket and bottom-entry disperser have demonstrated that batch-to-batch shade variation (ΔE*CMC 2:1) can be held below 0.25 only if the residual unreacted 2,7-dichlorobenzothiazole in the diazonium feed is controlled to <0.08% area percent by HPLC. The commercial dispersed dye paste is stabilized with lignin sulfonate and naphthalene sulfonate condensate, then micropulverized through a horizontal bead mill to a final particle size of D90 <1.0 µm, spray-dried to a moisture content ≤1.5%, and standardized to a strength of 200% relative to standard dye powder. The terminal product corresponds to colorants such as C.I. Disperse Yellow 54 or C.I. Disperse Orange 30 analogs, specifically designed for high-temperature exhaust dyeing of polyester and its blends with elastane. The molar ratio of 2,7-dichlorobenzothiazole to coupling component in the commercial recipe ranges from 1:0.98 to 1:1.00, with a slight excess of coupling component introduced to suppress diazo-salt side reactions. Regulatory conformance for textile formulations exported to the European Union demands verification against the ZDHC Manufacturing Restricted Substances List Version 3.1, with particular attention to the absence of amines listed under Entry 43 of EU REACH Annex XVII. Additionally, finished dye lots intended for Oeko-Tex-certified supply chains are tested according to DIN 54231:2005 (determination of dyes by extraction and chromatography) and must not release detectable levels of arylamines cleaved from the dispersed chromophore under the reductive conditions of EN 14362-1:2017. The dispersion properties are validated against ISO 105-Z11:1998 using a pressure filtration test at 5 bar, requiring a filtration time less than 60 seconds on a 47 mm diameter cellulose acetate membrane of 0.45 µm pore size. For import into the People’s Republic of China, compliance with GB 19601-2013 is mandatory, which limits the sum of 24 carcinogenic aromatic amines to ≤150 mg/kg in the dye product.

Operationally, the main bottleneck identified in production-scale campaigns is the exothermic nature of the diazo decomposition if the cooling system fails during the 18–24 hour holding period after coupling. Plants typically mitigate this risk by installing a redundant secondary brine loop capable of maintaining −5 °C fluid temperature and automated interlocking with the nitrite dosing pump. Published data for process analytical technology (PAT) integration with in-line Raman spectroscopy for this specific diazonium species remain limited, but off-line HPLC analysis with a C18 column at 30 °C using a water/acetonitrile gradient (detection at 280 nm) is standard practice.

Pilot-plant synthesis of a benzothiazolyl methoxyiminoacetamide fungicide candidate employing 2,7-dichlorobenzothiazole as the heterocyclic building block proceeds through a two-step sequence that first converts the dichloride into the corresponding 7-chloro-2-cyanobenzothiazole via nucleophilic substitution with copper(I) cyanide in quinoline at 180–195 °C, followed by cyclocondensation with α-oxo-2-methylbenzeneacetic acid methyl ester. The charge ratio of 2,7-dichlorobenzothiazole to CuCN is set at 1:1.7 (molar), and the reaction effluent is quenched into dilute sodium hydroxide containing sodium hypochlorite to destroy residual cyanide before phase separation and vacuum distillation of the nitrile intermediate at 150–160 °C and 5 mbar. The subsequent condensation requires an anhydrous potassium carbonate base in dimethylformamide at 85–90 °C for a duration of 12–16 hours, and the crude active ingredient is recrystallized from isopropanol/water to achieve a polymorphically stabilized product with a melting onset of 124–126 °C. The terminal active substance, a benzothiazole methoxyiminoacetamide, functions as a protective and curative fungicide in cereals and pome fruit at field application rates of 75–150 g a.i./ha. In its capacity as a registration-bound plant protection product intermediate, 2,7-dichlorobenzothiazole must be accompanied by an acute oral toxicity classification per OECD Test Guideline 402 and an Ames test report under OECD TG 471; residual methanol and DMF levels are capped at ≤100 ppm and ≤50 ppm respectively, aligned with ICH Q3C provisions extrapolated to agrochemical manufacturing. Process safety assessments for the cyanation step reference the cyanide destruction efficiency protocol of ASTM E1248-09, requiring post-quench free cyanide to measure below 0.5 mg/L by ion-selective electrode. Equipment-wise, the nitrile intermediate stream is handled exclusively in 316L stainless steel lines with a burst disc vented to a sodium hydroxide scrubber, a configuration found to eliminate valve clogging incidents that were common in campaign reports when bronze plug valves were temporarily substituted. For EU registration under Regulation (EC) 1107/2009, the five-batch analysis of the technical material must include a certified content of the active ingredient not less than 960 g/kg and a limit of ≤1.0% for the 7-chloro-2-unsubstituted benzothiazole byproduct, which exhibited herbicidal phytotoxicity in side-by-side glasshouse screening. Because of the thermal instability of the nitrile intermediate at temperatures above 220 °C, a dedicated thermal fluid system with a high-limit interlock set to 210 °C is specified by the engineering package; no commercial-scale campaign has been reported to deviate from this constraint without partial decomposition exceeding 4%.

Pharmaceutical Lead Optimization Scaffold in Kinase Inhibitor Series

Medicinal chemistry groups synthesizing ATP-competitive checkpoint kinase inhibitors utilize 2,7-dichlorobenzothiazole as a privileged fragment for Suzuki-Miyaura cross coupling at the 2-position or nucleophilic aromatic substitution at the 7-position to introduce amine motifs. In a typical library expansion protocol, the dichloride is dissolved in anhydrous 1,4-dioxane and submitted to Buchwald-Hartwig amination with a primary amine (1.2 eq.), using Pd₂(dba)₃ at 2 mol% and Xantphos at 4 mol% in the presence of Cs₂CO₃ at 100 °C for 18 hours. Purification by reverse-phase preparative HPLC delivers the mono-aminated adduct in 35–65% isolated yield. The resulting series of 2-amino-7-chlorobenzothiazole derivatives is screened against a panel of serine/threonine kinases, yielding lead compounds with IC₅₀ values in the mid-nanomolar range. All supplies intended for preclinical candidate advancement must be manufactured in accordance with ICH Q7A Good Manufacturing Practice for Active Pharmaceutical Ingredients; residual palladium is controlled to ≤5 ppm per ICH Q3D (Elemental Impurities) via inductively coupled plasma mass spectrometry. Solvent compliance with ICH Q3C residual solvent guidelines requires dioxane below 380 ppm and DMF below 880 ppm. The terminal output consists of a focused compound library and eventually a designated development candidate, such as a Chk1 or CDK7 inhibitor, for which the dichlorobenzothiazole scaffold provides a chlorinated handle for late-stage diversification while maintaining cLogP within acceptable drug-like space. No integrated PAT solution is deployed at this library synthesis scale, and reaction monitoring relies on thin-layer chromatography and low-resolution LC-MS; published data for continuous flow processing of this specific heterocycle are absent.